Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rhinocladiella mackenziei

ABSTRACT: Rhinocladiella mackenziei genome sequencing

PROVIDER: PRJNA340065 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR6439462_1.fastq.gz	Fastqsanger.gz
	SRR6439462_2.fastq.gz	Fastqsanger.gz
	SRR6439796.fastq.gz	Fastqsanger.gz
	SRR6439796_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Rhinocladiella similis

Project description:Rhinocladiella similis Genome sequencing

| PRJNA834904 | ENA

Rhinocladiella similis

Project description:Rhinocladiella similis overview

| PRJNA847315 | ENA

Rhinocladiella similis strain:Poitiers_1

Project description:Rhinocladiella similis strain:Poitiers_1 Genome sequencing and assembly

| PRJNA847151 | ENA

Rhinocladiella similis strain:LABIOMMI1217

Project description:Rhinocladiella similis strain:LABIOMMI1217 Genome sequencing and assembly

| PRJNA1068593 | ENA

Rhinocladiella similis strain:LABIOMMI1217

Project description:Rhinocladiella similis strain:LABIOMMI1217 Genome sequencing and assembly

| PRJNA1005689 | ENA

Chromoblastomycosis caused by Rhinocladiella aquaspersa.

Project description:A case of chromoblastomycosis of the hand caused by Rhinocladiella aquaspersa is described. The case was acquired locally in tropical Venezuela and was successfully treated with oral itraconazole.

| S-EPMC3885939 | biostudies-literature

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Rhinocladiella mackenziei

Project description:An extremely neurotropic fungus

| PRJNA293131 | ENA

Chromoblastomycosis caused by <i>Rhinocladiella similis</i>: Case report.

Project description:We report a case of chromoblastomycosis in lesions on the chest and foot. Itraconazole was chosen as the initial treatment for this patient, who was followed up for 8 months before becoming noncompliant. The pathogenic fungal species was identified as Rhinocladiella similis by ITS region sequencing. In vitro analyses indicate that the fungus was sensitive to posaconazole and itraconazole. This report presents R. similis as a new agent of chromoblastomycosis and raises the hypothesis that this species could be more resistant to some antifungals than R. aquaspersa.

| S-EPMC5397130 | biostudies-literature

Chromoblastomycosis caused by Rhinocladiella aquaspersa: first case report in Guatemala.

Project description:The authors report a case of 40-year-old male patient with a five-year history of chromoblastomycosis on his right leg. Diagnosis was performed by direct 40% KOH exam of skin scales, culture with micro- and macromorphologic analysis, and genotypic characterization (sequencing of a fragment of the ITS region and phylogenetic analysis) of the isolated fungus. Rhinocladiella aquaspersa was identified as the etiological agent. Initially, the treatment was with oral itraconazole 200mg/day for one year. However, the presence of "sclerotic cells" with filaments ("Borelli spiders") resulted in a change of medical treatment: a higher dose of itraconazole (400mg/day) and surgery, achieving clinical and mycological cure in one year. This is the first report of chromoblastomycosis caused by R. aquaspersa in Guatemala.

| S-EPMC6857580 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data